These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 4406943
1. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy. Matsumoto K, Omoto T, Beck H. Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943 [No Abstract] [Full Text] [Related]
7. The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy. Giuffrè R, Gambacorta D. Eur Neurol; 1971 Jan; 5(5):311-6. PubMed ID: 4943872 [No Abstract] [Full Text] [Related]
8. Interactions of L-dopa and amantadine in patients with Parkinsonism. Cox B, Danta G, Schnieden H, Yuill GM. J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097 [Abstract] [Full Text] [Related]
9. Administration of amandine to patients on optimum L-dopa dosage. Fehling C. Acta Neurol Scand Suppl; 1972 Jun; 51():119-20. PubMed ID: 4514335 [No Abstract] [Full Text] [Related]
16. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB, McHenry JT. Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]
17. Amantadine in the treatment of Parkinson's disease. Schwab RS, England AC, Poskanzer DC, Young RR. JAMA; 1969 May 19; 208(7):1168-70. PubMed ID: 5818715 [No Abstract] [Full Text] [Related]